Temporal changes in patient characteristics and outcomes in ST‐segment elevation myocardial infarction 2003–2018
Author:
Affiliation:
1. Minneapolis Heart Institute and Foundation at Abbott Northwestern Hospital Minneapolis Minnesota USA
2. The Carl and Edyth Lindner Center for Research and Education at The Christ Hospital Cincinnati Ohio USA
Publisher
Wiley
Subject
Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccd.28901
Reference28 articles.
1. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials
2. Comparison of Primary Coronary Angioplasty and Intravenous Thrombolytic Therapy for Acute Myocardial Infarction
3. A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial Infarction
4. Growth in Percutaneous Coronary Intervention Capacity Relative to Population and Disease Prevalence
5. Driving Times and Distances to Hospitals With Percutaneous Coronary Intervention in the United States
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Apelin is Peptide Increasing Tolerance of Organs and Cells to Hypoxia and Reoxygenation. The Signaling Mechanism;International Journal of Peptide Research and Therapeutics;2024-03-14
2. Activation of Cardiac δ2-Opioid Receptors Increases Heart Tolerance to Reperfusion;Bulletin of Experimental Biology and Medicine;2024-03
3. δ-Opioid receptor as a target for the creation of peptide drugs that increase cardiac resistance to reperfusion;The Siberian Journal of Clinical and Experimental Medicine;2023-08-14
4. Temporal Trends in Infarct Severity Outcomes in ST‐Segment–Elevation Myocardial Infarction: A Cardiac Magnetic Resonance Imaging Study;Journal of the American Heart Association;2023-08
5. δ-Opioid Receptor as a Molecular Target for Increasing Cardiac Resistance to Reperfusion in Drug Development;Biomedicines;2023-07-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3